VYCO announces that Richard P. Denness will be joi

VYCO announces that Richard P. Denness will be joining Vycor as its new Chief Executive Officer, replacing Ken Coviello. During this transition period, Ken will retain a role with the company on a consultancy basis. Since the acquisitions of NovaVision, Inc. and Sight Science Limited, Vycor has become an international group of greater complexity with several businesses. Richard Denness is a healthcare executive with global experience who has held senior management positions at UCB, Inc., Schwarz Pharma US, Schering-Plough and IVAX Corporation.

Kenneth T. Coviello, the current Chief Executive Officer of Vycor, has played a crucial role in the development of Vycor and its VBAS product line, which has been achieving excellent growth and progress in US and international markets. Ken had indicated to the Board a desire to pursue personal interests and pass the role on to a new executive to take Vycor forward to the next level, once an appropriate successor could be found.